Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,775
Recruiting: 1,497
Ph III recruiting: 183
Growth YoY: +6.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,528)

clinicaltrialsPublishedShowing 1,301–1,350 of 1,943 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07231068	A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation	recruiting	Phase 1 / Phase 2	153	Henan Genuine Biotech Co., Ltd.INDUSTRY	1	Nov 17, 2025	clinicaltrials
NCT07231159	Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots	recruiting	—	200	AdventHealthOTHER	1